XML 33 R16.htm IDEA: XBRL DOCUMENT v3.21.1

REVENUES (Tables)

3 Months Ended

Mar. 31, 2021

REVENUES

Schedule of Company's disaggregation of revenues

​

​	​	​	​	​	​	​	​
​		Three Months Ended March 31,					​
(U.S. dollars in thousands)		2021			2020		​
Pfizer	​	$	4,511	​	$	2,016	​
Brazil	​	$	—	​	$	3,015	​
Total revenues from selling goods	​	$	4,511	​	$	5,031	​
Revenues from license and R&D services	​	$	6,809	​	$	16,615	​

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration